# Teriparatide vs Abaloparatide: How They Differ | PepVault

Source: https://pepvault.app/peptides/compare/teriparatide-vs-abaloparatide

Last updated: 2026-11-18

Use: © PepVault. Read and cite with a link. Copying, bulk scraping, rewriting or republishing is not permitted (https://pepvault.app/terms#content).

[Library](https://pepvault.app/peptides) [Comparisons](https://pepvault.app/peptides/compare) Teriparatide vs Abaloparatide

Compared side by side

# Teriparatide vs abaloparatide: how they differ

Reviewed November 2026 [How we check the library](https://pepvault.app/about#library) [Published by PepVault](https://pepvault.app/guides/how-we-research)

## The short answer

Both are daily bone-building shots that act on the same receptor, PTH1: teriparatide is a copy of the first 34 amino acids of human parathyroid hormone, and abaloparatide a 34-amino-acid peptide modelled on a related hormone, PTHrP. Both are FDA-approved for osteoporosis at high risk of fracture, teriparatide as Forteo since 2002 and abaloparatide as Tymlos since 2017, for up to 2 years in most people. In their main trials, teriparatide cut new spine fractures by 65%, and on abaloparatide they fell from 4.2% on placebo to 0.6% over 18 months.

## Side by side

| Compared | [Teriparatide](https://pepvault.app/peptides/teriparatide) | [Abaloparatide](https://pepvault.app/peptides/abaloparatide) |
| --- | --- | --- |
| Category | Healing & recovery | Healing & recovery |
| Also known as | Forteo, Bonsity, PTH 1-34, rhPTH(1-34), LY333334 | Tymlos, BA058 |
| What it is | A daily shot of the active part of parathyroid hormone (Forteo) that builds new bone, rather than only slowing bone loss as most osteoporosis drugs do. | A daily shot (Tymlos) that builds new bone, a close relative of teriparatide modelled on a different natural hormone, PTHrP. |
| How it works | A bone-building copy of the first 34 amino acids of human parathyroid hormone (PTH), the active part of the 84-amino-acid hormone that controls calcium in bone and kidney. The pattern of exposure decides what it does: a short daily pulse stimulates the cells that build bone (osteoblasts) more than those that remove it, so new bone forms on the inner and outer surfaces, while a constant excess of PTH, as in an overactive parathyroid, breaks bone down. FDA-approved in 2002 (Forteo) for osteoporosis at high fracture risk in postmenopausal women, in men, and with long-term steroid use. | A bone-building 34-amino-acid peptide modelled on PTHrP, the parathyroid-hormone-related peptide (76% the same as its active part, 41% the same as teriparatide's PTH). It activates the PTH1 receptor on bone cells, and a daily dose stimulates the bone-building cells, so new bone forms on the inner and outer surfaces. FDA-approved in 2017 for postmenopausal women with osteoporosis at high fracture risk, and later for men; it is the sibling of teriparatide, with one dose and the same 2-year limit. |
| Commonly reported | Little day to day, sometimes joint pain, nausea, leg cramps or light-headedness after the first shots. FDA-approved since 2002, for up to 2 years in most people; some people also read about it for fracture healing, which the label does not cover. | Redness where the shot goes in, and dizziness or a fast heartbeat for a while after the first doses. FDA-approved since 2017, for up to 2 years. |
| Studied range | FDA label: 20 mcg, starting dose 20 mcg. | FDA label: 80 mcg, starting dose 80 mcg. |
| How often | Daily SubQ | Daily SubQ |
| Half-life | ~1 hour (FDA label) | ~1 hour (FDA label) |
| Route | SubQ injection | SubQ injection |
| Typical run | The label limits use to 2 years in a lifetime unless fracture risk stays or returns high. Its fracture trial ran a median of 19 months in women; the men's trial a median of 10 to 11 months. | The label does not recommend more than 2 years in a lifetime; its fracture trial ran 18 months, followed in the trial by alendronate, which kept the lower fracture risk through 24 more months. |
| Evidence | Established: clinical trials or FDA-approved use exists | Established: clinical trials or FDA-approved use exists |
| Common side effects | Joint pain, pain, nausea, dizziness, leg cramps, light-headedness on standing (first doses), brief rise in blood calcium | Injection site redness, dizziness, nausea, headache, palpitations, fatigue, high urine calcium |

Typical run: Community practice — opinions vary. Not a clinical recommendation.

<!--promo-->

PepVault for iPhone

## Taking teriparatide or abaloparatide? Log it in PepVault

Each dose, each vial and your step-ups in one place.

[Download on the App Store](https://apps.apple.com/app/apple-store/id6779318649?pt=129020030&ct=compound-vs-card-flow&mt=8)

7 days free on the yearly plan for new subscribers.

<!--/promo-->

## Week by week

Each entry’s cards by day window, as the compound pages show them. Day 1 is the day you start it.

### Teriparatide

- Day 1–14 · 20 mcg The first shots, sitting down
- Day 14–90 A short calcium pulse each day
- Day 90–365 New bone, built in the background
- Day 365–730 Fewer fractures, and the 2-year line

[Every card for teriparatide, with its sources](https://pepvault.app/peptides/teriparatide#weeks)

### Abaloparatide

- Day 1–14 · 80 mcg The first shots, sitting down
- Day 14–60 Redness where the shot goes in
- Day 60–365 New bone, built in the background
- Day 365–730 Fewer fractures, then the 2-year line

[Every card for abaloparatide, with its sources](https://pepvault.app/peptides/abaloparatide#weeks)

## With this comparison

### Teriparatide

- [Teriparatide: the full reference](https://pepvault.app/peptides/teriparatide)
- [Teriparatide dose guide](https://pepvault.app/lab/dosage/teriparatide)

### Abaloparatide

- [Abaloparatide: the full reference](https://pepvault.app/peptides/abaloparatide)
- [Abaloparatide dose guide](https://pepvault.app/lab/dosage/abaloparatide)

### Studies

- [Abaloparatide, teriparatide beat other drugs on spine BMD in men](https://pepvault.app/research/abaloparatide-chen-2025)
- [Teriparatide cut fracture risk vs bisphosphonates (RR 0.61)](https://pepvault.app/research/teriparatide-li-2024)
- [Abaloparatide: larger hip BMD gains than teriparatide at 24 weeks](https://pepvault.app/research/abaloparatide-hong-2023)
- [All 10 studies](https://pepvault.app/research#teriparatide)
- [Abaloparatide raised hip BMD around a virtual hip stem in ACTIVE](https://pepvault.app/research/abaloparatide-active-2024)
- [All 8 studies](https://pepvault.app/research#abaloparatide)

### Tools

- [Half-life calculator](https://pepvault.app/tools/peptide-half-life-calculator)

### Terms on this page

- [Peptide](https://pepvault.app/glossary/peptide)
- [Amino acid](https://pepvault.app/glossary/amino-acid)
- [Subcutaneous (SubQ)](https://pepvault.app/glossary/subcutaneous)
- [Half-life](https://pepvault.app/glossary/half-life)
- [Placebo](https://pepvault.app/glossary/placebo)
- [Parathyroid hormone (PTH)](https://pepvault.app/glossary/parathyroid-hormone)

## Questions people ask

### How long do teriparatide and abaloparatide last?

The half-life of teriparatide is ~1 hour (FDA label). The half-life of abaloparatide is ~1 hour (FDA label).

### How often are teriparatide and abaloparatide taken?

Teriparatide: daily SubQ. Route: SubQ injection. Abaloparatide: daily SubQ. Route: SubQ injection.

### How are teriparatide and abaloparatide dosed in research?

The FDA label range for teriparatide is 20 mcg, with a 20 mcg starting dose. The FDA label range for abaloparatide is 80 mcg, with a 80 mcg starting dose.

### What are the common side effects of teriparatide and abaloparatide?

For teriparatide, the library lists: joint pain, pain, nausea, dizziness, leg cramps, light-headedness on standing (first doses), brief rise in blood calcium. For abaloparatide: injection site redness, dizziness, nausea, headache, palpitations, fatigue, high urine calcium.

## Each one in full

- [Teriparatide: dosage, half-life & reference guide](https://pepvault.app/peptides/teriparatide)
- [Abaloparatide: dosage, half-life & reference guide](https://pepvault.app/peptides/abaloparatide)
- [Teriparatide dose guide](https://pepvault.app/lab/dosage/teriparatide)
- [Abaloparatide dose guide](https://pepvault.app/lab/dosage/abaloparatide)

<!--promo-->

[Track it in the app](https://apps.apple.com/app/apple-store/id6779318649?pt=129020030&ct=compound-vs-card-next&mt=8)

<!--/promo-->

<!--promo-->

PepVault for iPhone

## Taking teriparatide or abaloparatide? Log it in PepVault

Each dose, each vial and your step-ups in one place.

[Download on the App Store](https://apps.apple.com/app/apple-store/id6779318649?pt=129020030&ct=compound-vs-card-end&mt=8)

7 days free on the yearly plan for new subscribers.

[Explore the live demo](https://pepvault.app/login)

<!--/promo-->

<!--promo-->

PepVault for iPhone

## Taking teriparatide or abaloparatide? Log it in PepVault

Each dose, each vial and your step-ups in one place.

[Download on the App Store](https://apps.apple.com/app/apple-store/id6779318649?pt=129020030&ct=compound-vs-card-rail&mt=8)

7 days free on the yearly plan for new subscribers.

<!--/promo-->

## With this comparison

### Teriparatide

- [Teriparatide: the full reference](https://pepvault.app/peptides/teriparatide)
- [Teriparatide dose guide](https://pepvault.app/lab/dosage/teriparatide)

### Abaloparatide

- [Abaloparatide: the full reference](https://pepvault.app/peptides/abaloparatide)
- [Abaloparatide dose guide](https://pepvault.app/lab/dosage/abaloparatide)

### Studies

- [Abaloparatide, teriparatide beat other drugs on spine BMD in men](https://pepvault.app/research/abaloparatide-chen-2025)
- [Teriparatide cut fracture risk vs bisphosphonates (RR 0.61)](https://pepvault.app/research/teriparatide-li-2024)
- [Abaloparatide: larger hip BMD gains than teriparatide at 24 weeks](https://pepvault.app/research/abaloparatide-hong-2023)
- [All 10 studies](https://pepvault.app/research#teriparatide)
- [Abaloparatide raised hip BMD around a virtual hip stem in ACTIVE](https://pepvault.app/research/abaloparatide-active-2024)
- [All 8 studies](https://pepvault.app/research#abaloparatide)

### Tools

- [Half-life calculator](https://pepvault.app/tools/peptide-half-life-calculator)

### Terms on this page

- [Peptide](https://pepvault.app/glossary/peptide)
- [Amino acid](https://pepvault.app/glossary/amino-acid)
- [Subcutaneous (SubQ)](https://pepvault.app/glossary/subcutaneous)
- [Half-life](https://pepvault.app/glossary/half-life)
- [Placebo](https://pepvault.app/glossary/placebo)
- [Parathyroid hormone (PTH)](https://pepvault.app/glossary/parathyroid-hormone)

<!--promo-->

PepVault for iPhone

## Taking teriparatide or abaloparatide? Log it in PepVault

Each dose, each vial and your step-ups in one place.

[Download on the App Store](https://apps.apple.com/app/apple-store/id6779318649?pt=129020030&ct=compound-vs-card-sticky&mt=8)

7 days free on the yearly plan for new subscribers.

[Explore the live demo](https://pepvault.app/login)

<!--/promo-->

## More comparisons

- [All peptide comparisons](https://pepvault.app/peptides/compare)
- [Retatrutide vs Tirzepatide](https://pepvault.app/peptides/compare/retatrutide-vs-tirzepatide)
- [Semaglutide vs Tirzepatide](https://pepvault.app/peptides/compare/semaglutide-vs-tirzepatide)
- [Retatrutide vs Semaglutide](https://pepvault.app/peptides/compare/retatrutide-vs-semaglutide)
- [Mazdutide vs Tirzepatide](https://pepvault.app/peptides/compare/mazdutide-vs-tirzepatide)
- [Survodutide vs Retatrutide](https://pepvault.app/peptides/compare/survodutide-vs-retatrutide)
- [Orforglipron vs Semaglutide](https://pepvault.app/peptides/compare/orforglipron-vs-semaglutide)

## The library

- [The peptide reference library](https://pepvault.app/peptides)
- [Healing & recovery peptides](https://pepvault.app/peptides#healing)

## Free tools

- [The Dose Guide](https://pepvault.app/lab/dosage)
- [Half-life & active level](https://pepvault.app/tools/peptide-half-life-calculator)

PepVault is a research and tracking resource, not medical advice. Ranges are what studies used, never a dose for you. Brand names are trademarks of their owners; PepVault is independent of them.

PepVault is a private research and tracking tool, not medical advice. The information here is reference material from published literature and community use — always verify it and discuss any protocol with a qualified clinician before changing it.

© 2026 PepVault. Our text, data and tools may not be copied, scraped or republished without [permission](https://pepvault.app/terms#content).
